BNP Paribas Financial Markets
ATHE

BNP Paribas Financial Markets’s Alterity Therapeutics ATHE Stock Holding History

BNP Paribas Financial Markets’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55K Buy
10,239
+3,430
+50% +$14.9K ﹤0.01% 4841
2026
Q1 		$23.7K Sell
6,809
-100
-1% -$339 ﹤0.01% 5037
2025
Q4 		$21.3K Sell
6,909
-400
-5% -$1.53K ﹤0.01% 5009
2025
Q3 		$27.5K Sell
7,309
-881
-11% -$4.25K ﹤0.01% 4823
2025
Q2 		$33.5K Sell
8,190
-1,562
-16% -$6.13K ﹤0.01% 4396
2025
Q1 		$33.6K Buy
9,752
+962
+11% +$3.69K ﹤0.01% 4410
2024
Q4 		$29.1K Buy
+8,790
New +$14K ﹤0.01% 4617
2023
Q1 		– Sell
-70
Closed -$244 – 3860
2022
Q4 		$244 Buy
+70
New +$268 ﹤0.01% 3914

Other funds holding ATHE

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GT
Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
PCA
Providence Capital Advisors Charlotte, North Carolina $660M AUM 17.81% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return

BNP Paribas Financial Markets's ATHE Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Alterity Therapeutics (ATHE) stake by 50% in Q2 2026, buying an estimated $14.9K and bringing the position to 10,239 shares worth $55K. The position accounts for ﹤0.01% of the portfolio, ranked #4841.

BNP Paribas Financial Markets first reported a position in ATHE in Q4 2022 and has held it in 8 quarters since. 21 funds tracked by Wall St. Rank hold ATHE as of Q2 2026.

  • BNP Paribas Financial Markets held 10,239 shares of Alterity Therapeutics worth $55K as of Q2 2026.
  • BNP Paribas Financial Markets bought 3,430 Alterity Therapeutics shares in Q2 2026, an estimated $14.9K.
  • Alterity Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4841 holding.
  • BNP Paribas Financial Markets first reported a position in Alterity Therapeutics in Q4 2022 and has held it in 8 quarters since.
  • 21 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.